sac-TMT

Pharma

For Merck, 2027 is ‘another year of investment’

Merck sees 2027 “as another year of investment, as we invest behind our expansive pipeline and our new product launches,” CFO Caroline Litchfield said.

Angus Liu Oct 29, 2026 11:23am

Merck sees ‘pretty consistent’ data in sac-TMT’s 1st global ph. 3

Oct 26, 2026 11:30am

Merck’s sac-TMT posts major PFS benefit in PD-L1-negative NSCLC

Oct 25, 2026 5:15am